SCHIZO-AFFECTIVE TYPE OF PSYCHOSIS

Clinical trials for SCHIZO-AFFECTIVE TYPE OF PSYCHOSIS explained in plain language.

Never miss a new study

Get alerted when new SCHIZO-AFFECTIVE TYPE OF PSYCHOSIS trials appear

Sign up with your email to follow new studies for SCHIZO-AFFECTIVE TYPE OF PSYCHOSIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 1

Could schizophrenia be an autoimmune brain disease? new trial aims to find out

Disease control Recruiting now

This study explores whether some cases of schizophrenia or schizoaffective disorder are actually caused by the immune system attacking the brain. Researchers are giving an immune-suppressing drug called ocrelizumab to 40 adults aged 18-35 who developed psychosis after age 15. The…

Matched conditions: SCHIZO-AFFECTIVE TYPE OF PSYCHOSIS

Phase: PHASE1, PHASE2 • Sponsor: The Methodist Hospital Research Institute • Aim: Disease control

Last updated May 14, 2026 12:02 UTC

SCHIZO-AFFECTIVE TYPE OF PSYCHOSIS

Get alerted when new SCHIZO-AFFECTIVE TYPE OF PSYCHOSIS trials appear

Could schizophrenia be an autoimmune brain disease? new trial aims to find out